ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Subutex®, Sublingualtabletten:Indivior Schweiz AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
N07BC01 - BuprenorphineATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N07 - Other Nervous System Drugs

This group comprises other nervous system drugs, which cannot be classified in the preceding 2nd levels in ATC group N.

N07B - Drugs Used in Addictive Disorders

This group comprises drugs used for maintenance treatment of addictive disorders. Drugs used for detoxification are classified in V03A - All other therapeutic products.

N07BC - Drugs Used in Opioid Dependence

Low strength formulations of buprenorphine (equal or less than 0.4 mg) are classified in N02AE. Naltrexone is classified in N07BB - Drugs used in alcohol dependence.
Combinations of buprenorphine and naloxone are classified here.
Morphine used for treatment of opioid dependence is classified in N02AA01.

N07BC01 - Buprenorphine
StärkeAdm.RouteNote
 i 
 P 
 SL 
2025 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home